WEBVTT

1
00:00:00.240 --> 00:00:03.450
- Ozempic Maker Novo Nordis
shared more details about his

2
00:00:03.450 --> 00:00:05.550
experimental anti-obesity pill.

3
00:00:05.550 --> 00:00:08.820
Wednesday at the European
Association for the Study

4
00:00:08.820 --> 00:00:12.330
of Diabetes Annual
Meeting in Madrid, results

5
00:00:12.330 --> 00:00:14.340
of a small phase one clinical trial

6
00:00:14.340 --> 00:00:17.430
of Retin suggested the
pill could lead to more

7
00:00:17.430 --> 00:00:20.430
and faster weight loss than
the Danish Pharma Giants

8
00:00:20.430 --> 00:00:22.200
popular weekly injection.

9
00:00:22.200 --> 00:00:24.720
wegovy. Novo Nordis said that patients

10
00:00:24.720 --> 00:00:27.120
that took a once daily 50 milligram dose

11
00:00:27.120 --> 00:00:30.180
of Retin lost an average of 10.4%

12
00:00:30.180 --> 00:00:32.430
of their weight in just three months.

13
00:00:32.430 --> 00:00:35.490
And trial participants that
took two pills a day lost even

14
00:00:35.490 --> 00:00:38.940
more weight, 13.1% at three months.

15
00:00:38.940 --> 00:00:42.030
For comparison, a larger
clinical trial of Wegovy found

16
00:00:42.030 --> 00:00:44.040
that it helped users lose about 15%

17
00:00:44.040 --> 00:00:46.740
of their body weight over 68 weeks.

18
00:00:46.740 --> 00:00:48.395
The main difference between Retin

19
00:00:48.395 --> 00:00:51.180
and Wegovy, aside from
how it's administered, is

20
00:00:51.180 --> 00:00:54.180
that the former stimulates
two different gut hormones,

21
00:00:54.180 --> 00:00:56.190
while the latter only stimulates one.

22
00:00:56.190 --> 00:00:59.675
In addition to stimulating
glucagon-like Peptide one like

23
00:00:59.675 --> 00:01:03.000
Wegovy, Retin also stimulates amylin, both

24
00:01:03.000 --> 00:01:06.000
of which impact blood
sugar levels and appetite.

25
00:01:06.000 --> 00:01:07.590
The side effects of the pill were similar

26
00:01:07.590 --> 00:01:09.240
to current weight loss drugs

27
00:01:09.240 --> 00:01:11.580
and included nausea and vomiting.

28
00:01:11.580 --> 00:01:14.400
The company had previously
teased the experimental pill when

29
00:01:14.400 --> 00:01:17.520
it gave investors a brief
update on the trial in March.

30
00:01:17.520 --> 00:01:20.520
At the time, Nova Nordic,
CEO, Lars fear regard.

31
00:01:20.520 --> 00:01:22.680
Jorgensen told CNBC

32
00:01:22.680 --> 00:01:26.130
that Retin could develop into
a best in class medicine.

33
00:01:26.130 --> 00:01:28.860
However, Nova Nordisk isn't
alone in developing a weight

34
00:01:28.860 --> 00:01:31.200
loss pill that could help
patients that are hesitant

35
00:01:31.200 --> 00:01:33.090
to take weekly injections.

36
00:01:33.090 --> 00:01:34.380
Eli, Lilly, Pfizer,

37
00:01:34.380 --> 00:01:37.530
and Roche are all developing
weight loss pills.

38
00:01:37.530 --> 00:01:39.210
I'm Bruce Gill reporting for Quartz.

39
00:01:39.210 --> 00:01:41.490
Thanks for watching and
stick with qz.com. I.